BIO PLEXUS INC
8-K, 1998-01-09
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: DEAN WITTER PACIFIC GROWTH SECURITIES INC, N-30D, 1998-01-09
Next: THQ INC, POS AM, 1998-01-09



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                    FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported)   January 5, 1998


                                BIO-PLEXUS, INC.
             (Exact name of Registrant as specified in its Charter)

<TABLE>
<CAPTION>
<S>                                    <C>                           <C>
         Connecticut                          0-24128                   06-1211921
         -----------                          -------                   ----------
(State or Other Jurisdiction          (Commission File Number)        (I.R.S. Employer
      of Incorporation)                                              Identification No.)
</TABLE>

                  129 Reservior Road, Vernon, Connecticut 06066
               (Address of Principal Executive Offices) (zip code)

                                 (860) 870-6112
              (Registrant's telephone number, including area code)

                                       N/A
          (Former Name or Former Address, if Changed Since Last Report)
<PAGE>   2
ITEM 4.  CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANTS


         Effective January 5, 1998, the registrant dismissed its former
independent accountants, Price Waterhouse LLP of Hartford, Connecticut and
engaged Mahoney Sabol & Company, LLP of Hartford, Connecticut as its independent
accountants.

         During the two most recent audited fiscal years of the registrant and
through January 5, 1998, there have been no disagreements with Price Waterhouse
LLP on any matter of accounting principles or practices, financial statement
disclosure or auditing scope or procedure, which disagreements if not resolved
to the satisfaction of Price Waterhouse LLP would have caused them to make
reference thereto in their report on the financial statements for such years.

         The reports of the former independent accountants on the financial
statements of the registrant for fiscal years ended December 31, 1995 and 1996
contained no adverse opinion or disclaimer of opinion, nor were qualified or
modified as to uncertainty, audit scope, or accounting principles, except that
on the December 31, 1996 financial statements, the opinion dated April 11, 1997,
contained an explanatory paragraph relating to the registrant's ability to
continue as a going concern.

         The decision to change accountants was approved by the Board of
Directors of the registrant.

         The registrant has provided Price Waterhouse LLP with a copy of this
disclosure and has requested that Price Waterhouse LLP furnish it with a letter
addressed to the SEC stating whether or not it agrees with the above statements.
A copy of such letter, dated January 5, 1998 is filed as Exhibit 16 to this Form
8-K.
<PAGE>   3
                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                   BIO-PLEXUS, INC.

                                   By   /s/ Richard L. Higgins
                                        -------------------------------------
                                        Richard L. Higgins
                                        President and Chief Executive Officer


                                   Date
                                        -------------------------------------

<PAGE>   4
                                BIO-PLEXUS, INC.

                                  EXHIBIT INDEX

EXHIBIT NO.                         DESCRIPTION
- -----------                         -----------

16                                  Predecessor Accountants' Letter to SEC

<PAGE>   1
January 5, 1998


Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC  20549

Ladies and Gentlemen:

We have read Item 4 of Bio-Plexus' Form 8-K dated January 5, 1998 and are in
agreement with the statements contained in the first, second and third
paragraphs therein.

Yours very truly,


J. Timothy Reilly

Price Waterhouse LLP


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission